Skip to content

FP7H2020HORIZON

Karolinska Institutet

Country
SESweden
Defence projects
0
Projects, all programmes
705
As coordinator
254
EU contribution (CORDIS)
EUR 463,574,152
Active
2008 to 2026

Projects

705 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
P75NTRUnderstanding death-receptor signaling and physiology in the nervous system: A roadmap for the development of new treatments to neurodegenerative diseases and neurotraumaFP72014CoordinatorEUR 2,500,000
BETAIMAGEAn in vivo imaging approach to understand pancreatic beta-cell signal-transductionFP72014CoordinatorEUR 2,499,590
DENDRITICDEVMolecular Regulation of Dendritic Tree Formation during Neocortical DevelopmentH20202014CoordinatorEUR 100,000
COGOPTOThe role of parvalbumin interneurons in cognition and behaviorFP72014CoordinatorEUR 1,400,000
ENABLEEuropean Gram Negative Antibacterial EngineFP72014ParticipantEUR 877,980
MECHCOMMMechanotransduction in Cell-to-Cell CommunicationFP72014CoordinatorEUR 2,292,100
POCUMINTProof Of Concept Use of MTH1 Inhibitors as New Treatments for cancerFP72014CoordinatorEUR 105,990
REBOOTReleasing the brakes on adult plasticityFP72014CoordinatorEUR 1,918,070
ENANOMAPPEReNanoMapper - A Database and Ontology Framework for Nanomaterials Design and Safety AssessmentFP72014ParticipantEUR 257,700
ACTIONAggression in Children: Unraveling gene-environment interplay to inform Treatment and InterventiON strategFP72014ParticipantEUR 501,280
VIAVaccination In AtherosclerosisFP72013ParticipantEUR 565,001
AD BIOMARKERSCombining sensitive biomarkers for early diagnosis of AD: A multi-modal approachFP72013CoordinatorEUR 197,812
SUBCOPSuicide Bomber Counteraction and PreventionFP72013ParticipantEUR 49,219
GRAPHENEGraphene-Based Revolutions in ICT And BeyondFP72013ParticipantEUR 319,500
MINDVIEWMultimodal Imaging of Neurological DisordersFP72013ParticipantEUR 468,784
RARE-BESTPRACTICESPlatform for sharing best practices for management of rare diseasesFP72013ParticipantEUR 63,800
Athero-FluxTargeting novel lipid pathways for treatment of cardiovascular diseaseFP72013ParticipantEUR 456,000
NOROSENSORNOROSENSOR - A real-time monitoring system for airborne norovirusFP72013ParticipantEUR 175,800
PERICYTESCARThe role of pericytes in central nervous system scarring and fibrosisFP72013CoordinatorEUR 1,750,000
EUROCLASTExploring Functional and Developmental Osteoclast Heterogeneity in Health and DiseaseFP72013ParticipantEUR 265,425

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.